| Literature DB >> 25237284 |
Mohammad D H Hawlader1, Enbo Ma2, Emiko Noguchi3, Makoto Itoh4, Shams E Arifeen5, Lars Å Persson6, Sophie E Moore7, Rubhana Raqib5, Yukiko Wagatsuma2.
Abstract
Controversy persists as to whether helminth infections cause or protect against asthma and atopy. The aim of this study was to investigate the effects of helminth infection on asthma and atopy among Bangladeshi children. A total of 912 children aged 4.5 years (mean = 54.4, range = 53.5-60.8 months) participated in a cross-sectional study nested into a randomized controlled trial in Bangladesh. Ever-asthma, ever-wheezing and current wheezing were identified using the International Study of Asthma and Allergies in Childhood questionnaire. Current helminth infection was defined by the presence of helminth eggs in stools, measured by routine microscopic examination. Repeated Ascaris infection was defined by the presence of anti-Ascaris IgE ≥ 0.70 UA/ml in serum measured by the CAP-FEIA method. Atopy was defined by specific IgE to house dust mite (anti-DP IgE) ≥ 0.70 UA/ml measured by the CAP-FEIA method and/or positive skin prick test (≥ 5 mm). Anti-Ascaris IgE was significantly associated with ever asthma (odds ratio (OR) = 1.86, 95% CI: 1.14-3.04, highest vs. lowest quartile; P for trend 0.016). Anti-Ascaris IgE was also significantly associated with positive anti-DP IgE (OR = 9.89, 95% CI: 6.52-15.00, highest vs. lowest; P for trend < 0.001) and positive skin prick test (OR = 1.69, 95% CI: 1.01-2.81, highest vs. lowest, P for trend 0.076). These findings suggest that repeated Ascaris infection is a risk factor for asthma and atopy in rural Bangladeshi children. Further analysis is required to examine the mechanism of developing asthma and atopy in relation to helminth infection.Entities:
Keywords: Bangladesh; IgE; atopy; helminth infection; pediatric asthma
Year: 2014 PMID: 25237284 PMCID: PMC4139537 DOI: 10.2149/tmh.2013-19
Source DB: PubMed Journal: Trop Med Health ISSN: 1348-8945
Number of cells in pSC or aSC macrochatatete cell lineage from 0–6 h APF
| Characteristics | n | % |
|---|---|---|
| Age of the children (month) | 54.4 ± 0.7* | |
| Sex (boys) | 480 | 52.6 |
| Ever asthma | 164 | 18.0 |
| Ever wheezing | 412 | 45.2 |
| Current wheezing | 180 | 19.7 |
| Family history of asthma (positive) | 201 | 22.0 |
| Anti- | 636 | 69.7 |
| Anti-DP IgE (positive) | 404 | 44.3 |
| Mite antigen skin prick test (positive) | 139 | 15.7 |
| History of diarrhea in last 15 days (yes) | 123 | 13.5 |
| Socioeconomic status (calculated by asset score) | ||
| Poor | 148 | 16.2 |
| Below Middle | 187 | 20.5 |
| Middle | 180 | 19.7 |
| Upper Middle | 195 | 21.4 |
| Wealthy | 202 | 22.1 |
*Mean ± SD
Helminth egg counts of the study participants (n = 890)
| n | % | |
|---|---|---|
| 155 | 17.4 | |
| Low (< 5/hpf*) | 98 | 11.0 |
| Moderate (5–10/hpf) | 52 | 5.8 |
| High (> 10/hpf) | 5 | 0.6 |
| 156 | 17.5 | |
| Low (< 5/hpf) | 151 | 16.9 |
| Moderate (5–10/hpf) | 5 | 0.6 |
| High (> 10/hpf) | 0 | 0.0 |
| Hookworm eggs in stool (positive) | 4 | 0.4 |
| Few (< 5/hpf) | 3 | 0.3 |
| Moderate (5–10/hpf) | 1 | 0.1 |
| High (> 10/hpf) | 0 | 0.0 |
*High power field
Unadjusted and adjusted odds ratio with 95% CI interval for ever asthma with sex, stool egg count and anti-Ascaris IgE
| Ever asthma | ||||
|---|---|---|---|---|
| Yes n (%) | No n (%) | Unadjusted OR (95% CI) | Adjusted* OR (95% CI) | |
| Sex (n = 912) | ||||
| Boys | 96 (20.0) | 384 (80.0) | 1.34 (0.95–1.88) | 1.42 (0.98–2.07) |
| Girls | 68 (15.7) | 364 (84.3) | 1 | 1 |
| Positive | 24 (15.4) | 132 (84.6) | 0.78 (0.48–1.25) | 0.79 (0.47–1.33) |
| Negative | 139(18.9) | 595 (81.1) | 1 | 1 |
| Positive | 29 (18.6) | 127 (81.4) | 1.02 (0.65–1.60) | 1.19 (0.73–1.94) |
| Negative | 134(18.3) | 600 (81.7) | 1 | 1 |
| Anti- | ||||
| Positive | 125(19.7) | 511 (80.3) | 1.49 (1.00–2.20) | 1.34 (0.86–2.09) |
| Negative | 39 (14.1) | 237 (85.9) | 1 | 1 |
| Anti- | ||||
| 4th quartile | 55 (24.1) | 173 (75.9) | 1.93 (1.23–3.04) | 1.86 (1.14–3.04) |
| 3rd quartile | 39 (17.2) | 188 (82.8) | 1.26 (0.78–2.04) | 1.24 (0.74–2.08) |
| 2nd quartile | 31 (17.1) | 150 (82.9) | 1.25 (0.75–2.10) | 1.18 (0.68–2.04) |
| 1st quartile | 39 (14.1) | 237 (85.9) | 1 | 1 |
*Adjusted for sex, socioeconomic status, family history of asthma, history of diarrhea and intervention trial arm
**Anti-Ascaris IgE ≥ 0.70 UA/ml considered as positive
Unadjusted and adjusted odds ratio with 95% CI interval for anti-DP IgE with sex, stool egg count and anti-Ascaris IgE
| Positive anti-DP IgE* | ||||
|---|---|---|---|---|
| Yes n (%) | No n (%) | Unadjusted OR (95% CI) | Adjusted** OR (95% CI) | |
| Sex (n = 912) | ||||
| Boys | 236 (49.2) | 244 (50.8) | 1.52 (1.17–1.98) | 1.48 (1.11–1.96) |
| Girls | 168 (38.9) | 264 (61.1) | 1 | 1 |
| Positive | 64 (41.0) | 92 (59.0) | 0.84 (0.59–1.20) | 0.92 (0.63–1.35) |
| Negative | 332 (45.2) | 402 (54.8) | 1 | 1 |
| Positive | 65 (41.7) | 91 (58.3) | 0.87 (0.62–1.24) | 0.96 (0.66–1.41) |
| Negative | 330 (45.0) | 404 (55.0) | 1 | 1 |
| Anti- | ||||
| Positive | 352 (55.3) | 284 (44.7) | 5.34 (3.80–7.50) | 5.33 (3.77–7.53) |
| Negative | 52 (18.8) | 224 (81.2) | 1 | 1 |
| Anti- | ||||
| 4th quartile | 159 (69.7) | 69 (30.3) | 9.93 (6.57–15.00) | 9.89 (6.52–15.00) |
| 3rd quartile | 108 (47.6) | 119 (52.4) | 3.91 (2.62–5.82) | 3.90 (2.61–5.82) |
| 2nd quartile | 85 (47.0) | 96 (53.0) | 3.81 (2.51–5.80) | 3.92 (2.57–5.99) |
| 1st quartile | 52 (18.8) | 224 (81.2) | 1 | 1 |
*Anti-DP IgE ≥ 0.70 UA/ml considered as positive
**Adjusted for sex, socioeconomic status, family history of asthma, history of diarrhea and intervention trial arm
***Anti-Ascaris IgE ≥ 0.70 UA/ml considered as positive
Unadjusted and adjusted odds ratio with 95% CI interval for skin prick test for D. pteronyssinus antigen with sex, stool egg count and anti-Ascaris IgE
| Positive skin prick test* | ||||
|---|---|---|---|---|
| Yes n (%) | No n (%) | Unadjusted OR (95% CI) | Adjusted** OR (95% CI) | |
| Sex (n = 886) | ||||
| Boys | 75 (16.2) | 389 (83.8) | 1.08 (0.75–1.55) | 1.08 (0.75–1.55) |
| Girls | 64 (15.2) | 358 (84.8) | 1 | 1 |
| Positive | 11 (15.5) | 604 (84.5) | 1.00 (0.62–1.62) | 1.01 (0.62–1.65) |
| Negative | 24 (15.6) | 130 (84.4) | 1 | 1 |
| Positive | 114 (15.9) | 603 (84.1) | 0.89 (0.55–1.47) | 0.89 (0.54–1.50) |
| Negative | 22 (14.5) | 130 (85.5) | 1 | 1 |
| Anti- | ||||
| Positive | 108 (17.5) | 510 (82.5) | 1.62 (1.05–2.48) | 1.63 (1.06–2.50) |
| Negative | 31 (11.6) | 237 (88.4) | 1 | 1 |
| Anti- | ||||
| 4th quartile | 40 (18.0) | 182 (82.0) | 1.68 (1.01–2.79) | 1.69 (1.01–2.81) |
| 3rd quartile | 35 (16.1) | 183 (83.9) | 1.46 (0.87–2.46) | 1.46 (0.89–2.46) |
| 2nd quartile | 33 (18.5) | 145 (81.5) | 1.74 (1.02–2.96) | 1.76 (1.03–2.30) |
| 1st quartile | 31 (11.6) | 237 (88.4) | 1 | 1 |
*Skin prick test ≥ 5 mm considered as positive
**Adjusted for sex, socioeconomic status, family history of asthma, history of diarrhea and intervention trial arm
***Anti-Ascaris IgE ≥ 0.70 UA/ml considered as positive